Notice of New Budget Limitation for PAR-16-331 Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)

Notice Number: NOT-NS-18-071

Key Dates
Release Date: June 12, 2018

Related Announcements
PAR-16-331

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

National Eye Institute (NEI)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute on Drug Abuse (NIDA)

National Institute of Environmental Health Sciences (NIEHS)

Purpose

The purpose of this notice is to amend the award budget for PAR-16-331 "Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)."

?Section II. Award Information

?Currently Reads:

Award Budget

Application budgets are not limited, but need to reflect the actual needs of the proposed project. For most applications within the scope of this FOA, the expected direct cost for individual awards is $300,000-$500,000 per year.

Many applications will not need to request the maximum budget and the size and duration of the awards will vary depending upon the nature and scope of research programs.

Modified to Read:

Award Budget

Application Budget may not exceed $500,000 in direct costs per year.

?Many applications will not need to request the maximum budget and the size and duration of the awards will vary because the nature and scope of research programs will vary.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

David A. Jett, Ph.D.

?National Institute of Neurological Disorders and Stroke (NINDS)

?Telephone:  301-496-6035

?Email:  jettd@ninds.nih.gov